Trials / Unknown
UnknownNCT05628077
Prevalence and Risk Factors for Pain and Related Adverse Reactions Among Breast Cancer Survivors on Aromatase Inhibitors
Doctor of Medical Sciences
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,200 (estimated)
- Sponsor
- Peking University People's Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
We obtained the occurrence of pain sensation, pain mood, sleep, etc. during endocrine therapy in breast cancer patients through telephone follow-up, and analyzed risk factors through artificial intelligence
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | No intervention |
Timeline
- Start date
- 2022-12-30
- Primary completion
- 2023-03-20
- Completion
- 2023-04-20
- First posted
- 2022-11-28
- Last updated
- 2023-03-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05628077. Inclusion in this directory is not an endorsement.